Stocks
Vaxart Targets H1 2027 for Phase IIb COVID-19 Data, Backed by BARDA
Vaxart (VXRT) announced plans to release top-line data from its Phase IIb COVID-19 trial in the first half of 2027, supported by...
Vaxart (VXRT) announced plans to release top-line data from its Phase IIb COVID-19 trial in the first half of 2027, supported by...